Moderna, Inc. (MRNA)
Moderna, Inc. FCF to Net Income
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | (15.5%) | 152.3% | 113.5% | 95.4% | (262.3%) | 109.3% | 54.8% | 81.1% |
Moderna, Inc. (MRNA) FCF to Net Income comparison analysis
MRNA key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is Moderna, Inc.'s FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is 178.5%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual FCF to Net Income for Moderna, Inc. have been 92.4% over the past three years, and 106.0% over the past five years.
2) Is Moderna, Inc.'s FCF to Net Income Good?
As of today, Moderna, Inc.'s FCF to Net Income is 178.5%, which is higher than industry median of 84.2%. It indicates that Moderna, Inc.'s FCF to Net Income is Good.